Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients

Patients with severe chronic obstructive pulmonary disease (COPD) experience frequent acute exacerbations and require repeated courses of corticosteroid therapy, which may lead to adverse effects. Methotrexate (MTX) has anti-inflammatory properties. The objective of this study was to describe the ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergsøe, Christina Marisa, Sivapalan, Pradeesh, Saeed, Mohamad Isam, Eklöf, Josefin, Saghir, Zaigham, Sørensen, Rikke, Biering-Sørensen, Tor, Jensen, Jens-Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229017/
https://www.ncbi.nlm.nih.gov/pubmed/34073252
http://dx.doi.org/10.3390/biomedicines9060604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229017/
https://www.ncbi.nlm.nih.gov/pubmed/34073252
http://dx.doi.org/10.3390/biomedicines9060604

Ejemplares similares